ICMR, Panacea Biotec initiate first dengue vaccine Phase 3 clinical trial in India with DengiAll Yakshi Chugh16 Aug 2024 5:46 PM ISTThe Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue...
Health Bulletin 16/ August/ 2024 Yakshi Chugh16 Aug 2024 5:30 PM ISTHere are the top health stories for the day:PM Modi announces 75,000 new medical seats to be added in the next 5 years Lamenting that middle-class...
ICMR, Panacea Biotec begin first ever Phase 3 clinical trial for dengue vaccine in India Ruchika Sharma16 Aug 2024 2:54 PM ISTNew Delhi: The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for...
Clarify, revise protocol for phase 3 trial of Dengue Tetravalent Vaccine: CDSCO panel tells Panacea Biotec Medical Dialogues Team2 Oct 2021 11:30 AM ISTNew Delhi: In response to Panacea Biotec's proposal to conduct a phase 3 clinical trial of its Dengue Tetravalent Vaccine, the Subject Expert...
Panacea Biotec DengiAll vaccine completes phase 1/2 study Ruchika Sharma26 Sept 2020 11:45 AM ISTDengiAll is a single-dose live-attenuated tetravalent vaccine.
